Riverside & University of Virginia RadioSurgery Center can now treat tumors non-surgically anywhere on the body with the addition of Synergy S™
Newport News, VA – Riverside & University of Virginia Radiosurgery Center have been using the Gamma Knife technology to treat brain tumors for over one year. The Synergy S technology adds the ability to treat larger cancer tumors anywhere on the body. The Riverside & University of Virginia Radiosurgery Center is one of four centers in the nation that has Gamma Knife and Synergy S treatment capabilities.
With an overall goal of improving the patient’s quality of life and chance of long-term survival, the Riverside & University of Virginia Radiosurgery Center brings an experienced team of neurosurgeons, radiation oncologists and physicists, as well as, highly trained staff.
Synergy S is capable of performing 4D Adaptive™ Radiation Therapy, a new Image Guided Radiation Therapy (IGRT) treatment approach that relies on images of anatomy and disease to guide radiation delivery precisely to the tumor while minimizing damage to surrounding healthy tissue.
To determine the precise location of tumors and normal surrounding tissues, traditional radiotherapy calls for imaging studies to be done several days before treatment. Synergy S will enable the Riverside Neurosciences team to obtain images the day of treatment with the patient in the exact position he or she will be treated in. This means not only unparalleled precision in tumor targeting and patient positioning, but also the ability to increase the dose to the tumor by virtue of more certainty in the tumor’s location.
The Gamma Knife®
Considered one of the most advanced neurosurgical tools available, the Gamma Knife® allows a neurosurgeon to perform brain surgery without a scalpel and without actually entering the skull. The Gamma Knife® treatment uses 201 highly focused beams of Cobalt-60 radiation to produce biological effects on tissues inside the skull. Because of the exceptional precision involved, treatment is typically carried out in a single sitting and potential damage to healthy surrounding tissue is minimized. Over 120 patients have been treated at the Riverside facility.
Radiosurgery Center Partnership
Riverside’s partner in this venture, the University of Virginia Health System, is one of the leading international authorities on radiosurgery.
Dr. Ladislau Steiner, Alumni Professor of Neurosurgery and Radiology at the University of Virginia and Director of the Gamma Knife Center at U.Va. is part of the Medical Advisory Panel for Riverside’s Gamma Knife Center. Dr. Steiner is recipient of the 2003 Gold Medal of Honor from the World Federation of Neurosurgical Societies for lifetime contributions to neurosurgery practice and teaching and of the Sugita Award from the International Society for Neurosurgical Technology and Instrument Invention. He is a widely recognized pioneer in radiosurgery applications as well as in the development of the Gamma Knife.
The University of Virginia Medical Center has been recognized by U.S. News and World Report, Best Doctors in America and other organizations as one of the top medical institutions in the country. The U.Va. School of Medicine continues to make discoveries resulting in new and better therapies, especially in the areas of cancer, cardiovascular disease, neuro-degenerative disease and vaccine development.
Riverside will be the first healthcare provider in southeastern Virginia to have a radiosurgery facility offering both intra (Gamma Knife) - and extra (Synergy S)-cranial capabilities, and is the first in Virginia to utilize Synergy S to benefit patients. The combination of both devices makes Riverside and University of Virginia’s Radiosurgery Center a true center of excellence for stereotactic radiosurgery and a valuable health resource for our region.
Published: June 7, 2007